Printer Friendly
The Free Library
14,718,654 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Comprehensive Summary Of 2006 Biopharma Deals.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c45491) has announced the addition of "Partneringreview 2006: Biopharma Deal Making By Industry Sector - Academic/Government" to their offering.

This report contains a subset A group of commands or functions that do not include all the capabilities of the original specification. Software or hardware components designed for the subset will also work with the original.  of the data provided in "PartneringReview 2006: BioPharma Deal Making ", which is a comprehensive summary of the years BioPharma deals, providing a broad perspective of the deal making activity during 2005:
 - Want to know what your competitors are doing?
 - Want to benchmark your deals against others in your therapeutic
   area?
 - See how the finances of different deal types compare?
 - Want to know what the early, clinical and late stage developments
   are?
 - Interested in new merger and acquisition activity over 2005?
 - Curious about financing investments from lead investors?


PartneringReview 2006: BioPharma Deal Making provides:
 - Fully categorized overviews of deals, alliances and financings
 - Financial information where disclosed
 - Specialized indexes including deal type, therapy area, industry
   sector, financials and stage of development
 - An alphabetical index of company activity
 - Interactive PDF format for easy exploration


The report provides an in depth view into the academic and government deals and alliances announced in 2005, in a clear and accessible format.

The report analyzes deals announced by company, therapy focus and development stage. Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront and milestone “Milemarker” redirects here. For the American indie rock band, see Milemarker (band).

A milestone or kilometre sign is one of a series of numbered markers placed along a road at regular intervals, typically at the side of the road or in a median.
 payments, where disclosed dis·close  
tr.v. dis·closed, dis·clos·ing, dis·clos·es
1. To expose to view, as by removing a cover; uncover.

2. To make known (something heretofore kept secret).
.

Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report.

For more information visit http://www.researchandmarkets.com/reports/c45491
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 20, 2006
Words:261
Previous Article:In-Depth View Of Over 1600 Deals And Alliances Announced In Infectious Diseases Between 2001 And 2006.
Next Article:Identify the Main Furniture Manufactures Operating in the Philippine's Market.
Topics:



Related Articles
Fully Categorized Overviews of Deals, Alliances and Financings are Available in PartneringReview 2006: BioPharma Deal Making.
Discover the Dermatological Disease Deals and Alliances Announced in 2005.
Research and Markets: Discover 2005's Biopharma Deal Making By Deal Type for the Area of Licensing.
A real media player: Bernard Beal of M.R. Beal & Co. looks to entertainment-related firms for growth.(M R. Beal & Co widens its services)
Comprehensive Summary of Deals Made in Biopharma's Autoimmune/Inflammation Sector in 2005 Now Available.
Comprehensive Summary Of Biopharma Deals For 2006.
Biopharma Deals 2006: Focus on Metabolic Diseases.
Biopharma Deal Making: A Focus On The Blood/Lymphatic System.
Biopharma Deal Making: A Focus On Sensory Organ/Oral Health.
Research and Markets: Gain An Insight In To AVI Biopharma Inc.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles